Answers are grounded in this paper and cite their sources.
An outbreak of respiratory illness, officially named Coronavirus Disease 2019 (COVID-19), has spread rapidly worldwide. The domestic situation has been controlled, now the resumption of production and work as well as people's normal life has been accelerating. We focused this article on laboratory changes in the infection confirmed case of COVID-19 hospitalized to clarify the immune characterizations and coagulation system. Coagulation dysfunction is common in patient with COVID-19, especially fibrinogen and APTT, and the degree of elevation is related to immune characteristics. As the disease recovers, fibrinogen, APTT and CD8+ T cells also return to normal.
No takes yet. Share an insight, caveat, or question.
Zhi-jun et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: